Page last updated: 2024-12-07
bacimethrin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 96318 |
SCHEMBL ID | 459540 |
MeSH ID | M0153539 |
Synonyms (25)
Synonym |
---|
brn 0610202 |
nsc 66577 |
3690-12-8 |
bacimetrin |
nsc-66577 |
nsc66577 |
4-amino-5-hydroxymethyl-2-methoxypyrimidine |
4-amino-2-methoxy-5-pyrimidinemethanol |
BACIMETHRIN , |
2-methoxy-4-amino-5-hydroxymethylpyrimidine |
bacimethrine |
5-pyrimidinemethanol, 4-amino-2-methoxy- |
(4-amino-2-methoxypyrimidin-5-yl)methanol |
AKOS006276206 |
378z7n5rel , |
unii-378z7n5rel |
5-25-13-00322 (beilstein handbook reference) |
bacimethrin [mi] |
4-amino-5-(hydroxymethyl)-2-methoxypyrimidine |
SCHEMBL459540 |
DTXSID70190381 |
BS-16688 |
Q27256660 |
D83536 |
SB57694 |
Research Excerpts
Overview
Bacimethrin is an analog of the 4-amino-5-hydroxymethyl-2-methylpyrimidine (HMP) moiety of thiamine. It inhibits the growth of Salmonella enterica serovar Typhimurium.
Excerpt | Reference | Relevance |
---|---|---|
"Bacimethrin is an analog of the 4-amino-5-hydroxymethyl-2-methylpyrimidine (HMP) moiety of thiamine and inhibits the growth of Salmonella enterica serovar Typhimurium on a defined medium. " | ( Action of the thiamine antagonist bacimethrin on thiamine biosynthesis. Croal, LR; Downs, DM; Zilles, JL, 2000) | 2.03 |
Actions
Excerpt | Reference | Relevance |
---|---|---|
"Bacimethrin does not cause repression of the genes coding for the thiamin biosynthetic enzymes." | ( The mechanism of action of bacimethrin, a naturally occurring thiamin antimetabolite. Begley, TP; Lee, J; Melnick, JS; Perkins, J; Reddick, JJ; Saha, S, 2001) | 1.33 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Pathways (1)
Pathway | Proteins | Compounds |
---|---|---|
bacimethrin and bacimethrin pyrophosphate biosynthesis | 4 | 14 |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 20.14
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.14) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |